Pyridoxamine Supplement Sale Should Cease Following IND Filing - Petition
This article was originally published in The Tan Sheet
Executive Summary
Dietary supplements containing pyridoxamine should be removed from the market following the filing of an investigational new drug application for the ingredient, according to a citizen petition filed July 29